Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Feb;35(1):82-85.
doi: 10.12669/pjms.35.1.415.

The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey

Rahsan Yildirim  1 , Gulden Sincan  2
Affiliations

The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey

Rahsan Yildirim et al. Pak J Med Sci. 2019 Jan-Feb.

Abstract

Objective: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions.

Methods: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we used T test for comparison of groups. We evaluated the parameters affecting surveillance with cox regression analysis.

Results: The most common histological types of nonhodgkins lymphoma was diffuse large b cell lymphoma (n: 63, 78.75%). Thirty-nine percent of all patients had anemia, 32% had hypoalbunemia, 71.25% had elevated serum LDH, 32.5% had elevated serum ß2 microglobulin value. Advanced age, the presence of bulky disease, elevated Ki-67 level, IPI score, refractory to first line treatment were found to be correlated with shorter survival time. We treated 77 (96.25%) patients with doxorubicin containing regimen. Complete and partial remission rates of first line treatment were 77.5% and 10%, respectively. Seven (8.75%) patients died because of disease progression and 1 (1.25%) patient died due to sepsis.

Conclusion: The frequency of lymphoma subtypes, clinical characteristics, treatment outcomes and survival rate vary from region to region. Therefore it is important to determine dissimilarity of these parameters for improve of survey.

Keywords: Laboratory findings; Nonhodgkin lymphoma; Response to treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Similar articles

See all similar articles

References

    1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas:clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16(8):2780–2795. doi:10.1200/JCO.1998.16.8.2780. - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics. Cancer J Clin. 2015;65:5–29. doi:10.12691/jcrt-4-2-3. - PubMed
    1. Aisenberg AC. Coherent view of non-Hodgkin's lymphoma. J Clin Oncol. 1995;13:2656–2675. doi:10.1200/JCO.1995.13.10.2656. - PubMed
    1. Isikdogan A, Ayyildiz O, Buyukcelik A, Arslan A, Tiftik N, Buyukbayram H, et al. Non-Hodgkin's lymphoma in southeast Turkey:clinicopathologic features of 490 cases. Ann Hematol. 2004;83(5):265–269. doi:10.1007/s00277-003-0812-0. - PubMed
    1. Barista I, Tekuzman G, Firat D, Baltali E, Kansu E, Kars A, et al. Non-Hodgkin's Lymphomas in Turkey:Eighteen Years'Experience at the Hacettepe University. Jpn J Cancer Res. 1994;85:1200–1207. doi:10.1111/j.1349-7006.1994.tb02930.x. - PMC - PubMed

LinkOut - more resources